Therapeutic Effects of Hydrogen in Animal Models of Parkinson's Disease
Table 1
Comparison of representative MPTP-PD models. Each written model is representative and reproducible examples of MPTP-PD model because many researchers modify their own protocols in creating MPTP-PD model.
Acute
Sub-acute
Chronic
Dose of MPTP
20 mg/kg
30 mg/kg
30 or 45 mg/kg/day (using osmotic pump)
Duration of MPTP
3 or 4 times at 2 h interval
Once a day for 5 consecutive days
28 days
Administration of MPTP
i.p.
i.p.
i.p. (30 mg) s.c. (45 mg)
Extirpation of brain
7 days after injection
21 days after injection
28 days after pump infusion
Anticipating nigral cell loss
70%
40%
50%
Anticipating striatal fiber loss
90%
50%
50%
Notable features
Undesirable death (~10%)
Less or no undesirable death
Nitrated α-synuclein accumulation
Behavioral alteration (open-field test) Formation of inclusion bodies (stained for α-synuclein, ubiquitin) Loss of noradrenergic neurons